NellOne Therapeutics, Inc. (NellOne) is a regenerative medicine company that has been spun out of the U.S. Department of Energy's Oak Ridge National Laboratory by Battelle Ventures to create and commercialize protein therapeutics for restoring cardiac muscle mass and function in patients recovering from heart attacks. (See June 4, 2008, press release.)